XSHE
002817
Market cap306mUSD
Jun 11, Last price
7.38CNY
1D
0.14%
1Q
13.02%
Jan 2017
-55.30%
IPO
15.82%
Name
Anhui Huangshan Capsule Co Ltd
Chart & Performance
Profile
Anhui Huangshan Capsule Co., Ltd. manufactures and sells hollow and enteric hollow capsules in China. It offers entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colon soluble vacant gelatin capsules, hydroxypropyl methyl cellulose and hydroxypropyl starch hollow capsules, and pulluan capsules. The company was founded in 1989 and is based in Xuancheng, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 473,483 2.31% | 462,771 8.04% | 428,319 12.75% | |||||||
Cost of revenue | 397,254 | 376,323 | 360,282 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 76,229 | 86,449 | 68,036 | |||||||
NOPBT Margin | 16.10% | 18.68% | 15.88% | |||||||
Operating Taxes | 9,379 | 6,832 | ||||||||
Tax Rate | 12.30% | 7.90% | ||||||||
NOPAT | 66,850 | 79,617 | 68,036 | |||||||
Net income | 49,253 -24.07% | 64,863 6.60% | 60,850 6.97% | |||||||
Dividends | (18,037) | (17,091) | ||||||||
Dividend yield | 0.70% | 0.64% | ||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 1,912 | 274 | ||||||||
Long-term debt | 44 | 10,221 | 274 | |||||||
Deferred revenue | 13,882 | 30,095 | 31,203 | |||||||
Other long-term liabilities | 1 | 1 | ||||||||
Net debt | (341,598) | (233,477) | (370,094) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 63,511 | 99,856 | 83,017 | |||||||
CAPEX | (6,582) | |||||||||
Cash from investing activities | (208,066) | |||||||||
Cash from financing activities | (7,106) | |||||||||
FCF | 99,567 | 105,578 | 58,321 | |||||||
Balance | ||||||||||
Cash | 341,642 | 243,759 | 370,641 | |||||||
Long term investments | 2 | 1,851 | ||||||||
Excess cash | 317,968 | 222,471 | 349,225 | |||||||
Stockholders' equity | 763,113 | 752,004 | 769,063 | |||||||
Invested Capital | 613,698 | 720,560 | 527,744 | |||||||
ROIC | 10.02% | 12.76% | 13.04% | |||||||
ROCE | 8.15% | 9.12% | 7.71% | |||||||
EV | ||||||||||
Common stock shares outstanding | 299,098 | 294,834 | 299,098 | |||||||
Price | 6.26 -28.54% | 8.76 -2.23% | 8.96 4.01% | |||||||
Market cap | 1,872,355 -27.51% | 2,582,745 -3.63% | 2,679,920 4.01% | |||||||
EV | 1,532,079 | 2,349,905 | 2,310,278 | |||||||
EBITDA | 122,238 | 132,330 | 111,108 | |||||||
EV/EBITDA | 12.53 | 17.76 | 20.79 | |||||||
Interest | 28 | 24 | 2,047 | |||||||
Interest/NOPBT | 0.04% | 0.03% | 3.01% |